Should You Buy Ocugen Stock in March?

Shares in Ocugen(NASDAQ:OCGN), a Malvern, Penn., biopharmaceutical company, were below $0.30 a share as recently as Dec. 15, and now, they’re just above $8 a share. That’s after climbing to $10 a share earlier this week. Over the past three months, the company’s shares have risen more than 2,500%.
What’s behind all of this investor enthusiasm? It isn’t the company’s balance sheet, at least not yet. Ocugen is a clinical-stage company whose early-stage gene therapies are aimed at preventing or suppressing…

Click here to view the original article.